摘要
目的:探讨青春前期特发性矮小(ISS)患儿甲状腺功能正常,但游离甲状腺素(FT4)处于正常低值时,小剂量甲状腺素(L-T4)对ISS患儿重组人生长激素(rhGH)敏感性的影响。方法选取86例甲状腺功能正常,但血清FT4浓度处于正常值的第3~25百分位之间,首次确诊为ISS的青春前期患儿进行前瞻性研究,根据治疗方案不同随机分为两组,即:rhGH+L-T4组和rhGH组。 rhGH+L-T4组给予rhGH[0.15~0.20 U/(kg· d)]+L-T4(0.5~1.5μg/kg)干预,rhGH组给予rhGH([0.15~0.20 U/(kg· d)]+安慰剂干预,观察治疗4个月后患儿治疗期间净获身高(ΔHt)、体质量指数(BMI)、年龄的身高标准差分值(HtSDS-CA)、胰岛素样生长因子-1(IGF-1)、胰岛素样生长因子结合蛋白-3( IGFBP-3)、促甲状腺素( TSH )、FT4等各项指标的变化。结果经治疗4个月后, rhGH+L-T4组患儿ΔHt、FT4和IGF-1较rhGH组增高,且差异有统计学意义( t =5.025,49.332,4.050, P均<0.05);HtSDS-CA较rhGH组稍增高,但差异未见统计学意义( t=1.517,P=0.133);BMI、TSH和IGFBP-3与rhGH组相比差异未见统计学意义(t=0.544,-1.440,0.974,P均>0.05)。结论对于甲状腺功能正常、FT4处于正常低值的青春前期ISS患儿,小剂量甲状腺素短期干预可增强生长激素敏感性,且不会增加肥胖发生率,其机制可能与调控GH-IGF-1信号传导通路的IGF-1水平有关。
Objective To evaluate the effects of levothyroxine ( L-T4 ) on recombinant human growth hormone growth ( rhGH ) sensitivity in prepubertal children with idiopathic short stature ( ISS ) . Methods Eighty-six prepubertal children with ISS and free T4 ( FT4 ) concentrations between the 3 rd and the 25 th percentiles were enrolled in this study to receive either 4-month rhGH plus L-T4 or 4-month rhGH plus placebo treatment.Delta height ( end beginning stature) , the standard deviation score of height for chronological age(HtSDSca), body mass index(BMI), IGF-1, IGFBP-3, TSH and FT4 were investigated during treatment.Results After 4-month thyroid supplementation and/or rhGH ad-ministration, rhGH plus L-T4 group had significantly increase in delta height, FT4 and IGF-1 concentra-tions compared with rhGH plus placebo group ( t=5.025 , 49.332 , 4.050 , P〈0.05 ) , and they exhibi-ted a slightly increase in HtSDS-CA (t=1.517,P=0.133).Howerver, there was no obviously signifi-cant change in BMI, TSH and IGFBP-3(t=0.544, -1.440, 0.974, P〉0.05).Conclusions Sup-plementation with L-T4 for 4-month promotes sensitivity of rhGH and does not increase the obesty rate in prepubertal ISS children with low-normal FT4 , and the mechanism can be connected with IGF-1 which involved GH-IGF-1 pathway.
出处
《中国实用医刊》
2015年第22期1-3,共3页
Chinese Journal of Practical Medicine
基金
河南省医学科技攻关计划项目(201303092),河南省卫生科技创新型人才工程专项经费资助(豫卫科2010-52号)
关键词
特发性矮小
重组人生长激素
甲状腺素
Idiopathic short stature
Recombinant human growth hormone
Levothyroxine